Page last updated: 2024-10-22

albendazole and Psoriasis

albendazole has been researched along with Psoriasis in 1 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether albendazole, an anti-helmintic drug that regulates epithelial cell function in various systems, inhibits keratinocyte proliferation in models of psoriasis."3.96Albendazole negatively regulates keratinocyte proliferation. ( Colantoni, A; Di Fusco, D; Di Grazia, A; Dinallo, V; Laudisi, F; Marafini, I; Monteleone, G; Monteleone, I; Stolfi, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Di Fusco, D1
Stolfi, C1
Di Grazia, A1
Dinallo, V1
Laudisi, F1
Marafini, I1
Colantoni, A1
Monteleone, I1
Monteleone, G1

Other Studies

1 other study available for albendazole and Psoriasis

ArticleYear
Albendazole negatively regulates keratinocyte proliferation.
    Clinical science (London, England : 1979), 2020, 04-17, Volume: 134, Issue:7

    Topics: Albendazole; Animals; cdc25 Phosphatases; Cell Line; Cell Proliferation; Cytokines; Dermatologic Age

2020